License and distribution agreement for Kigabeq in the United Kingdom
29 octobre 2019

ORPHELIA Pharma will be present at CPhI in Frankfurt

Caroline Lemarchand, Pharmaceutical Development Director of ORPHELIA Pharma will be present to the 2019 CPhI to be held in Frankfurt (Germany), November 5 – 7, 2019.

Please meet us there (contact: caroline.lemarchand@orphelia-pharma.eu).